Announcement on holding a briefing on 2024 semi-annual results and cash dividends
Yakang Biology: Legal Opinion of Jiangsu Century Tongren Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Jiangsu Jicui Yakang Biotechnology Co., Ltd.
Yakang Biotech: Announcement of Resolutions of Yakang Biotech\'s 2024 First Extraordinary General Meeting of Shareholders
Legal Opinion of Jiangsu Century Tongren Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Jiangsu Jicui Yakang Biotechnology Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Yakkang Biotech
Materials of the 2024 First Extraordinary General Meeting of Shareholders of Yakkang Biotech
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on holding the 2023 annual and 2024 first quarter performance and cash dividend briefing.
Announcement of the resolutions of the 2023 annual shareholder meeting of Yaokang Biotech.
Legal Opinion Letter from Jiangsu Shiji Tongren Law Firm Regarding the 2023 Shareholders' Meeting of Jiangsu Jicui Yaokang Biotechnology Co., Ltd.
YaoKang Biological's 2023 Annual Shareholders' Meeting Information.
Announcement on the abolished portion of restricted shares granted that have not yet been vested
2023 Internal Control Evaluation Report
2023 Audit Committee Performance Report
Report on the performance of supervisory duties by the Board of Directors and the Audit Committee on the accounting firm
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Working system for special meetings of independent directors
Notice on convening the 2023 Annual General Meeting of Shareholders
Announcement on the resignation of core technical personnel and the addition of certified core technical personnel
Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Managers
No Data
No Data